{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:00:39Z","timestamp":1789646439655,"version":"4.0.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique\u2014FNRS","doi-asserted-by":"publisher","award":["Clinical Master Specialist Applicant for a Ph.D"],"award-info":[{"award-number":["Clinical Master Specialist Applicant for a Ph.D"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"crossref","award":["SNSF 320030_188549"],"award-info":[{"award-number":["SNSF 320030_188549"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"crossref","award":["325130_204361"],"award-info":[{"award-number":["325130_204361"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["634238"],"award-info":[{"award-number":["634238"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s40266-023-01029-1","type":"journal-article","created":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T18:39:44Z","timestamp":1684867184000},"page":"551-561","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Benzodiazepine Receptor Agonists Use and Cessation Among Multimorbid Older Adults with Polypharmacy: Secondary Analysis from the OPERAM Trial"],"prefix":"10.1007","volume":"40","clinical-trial-number":[{"clinical-trial-number":"nct02986425","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4173-8581","authenticated-orcid":false,"given":"Fran\u00e7ois-Xavier","family":"Sibille","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"de Saint-Hubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Henrard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole Elodie","family":"Aubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namiko Anna","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Dalleur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Rodondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilma","family":"Knol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"O\u2019Mahony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Schwenkglenks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Spinewine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,23]]},"reference":[{"issue":"7526","key":"1029_CR1","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1136\/bmj.38623.768588.47","volume":"331","author":"J Glass","year":"2005","unstructured":"Glass J, Lanct\u00f4t KL, Herrmann N, Sproule BA, Busto UE. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ (Clin Res Ed). 2005;331(7526):1169.","journal-title":"BMJ (Clin Res Ed)"},{"issue":"2","key":"1029_CR2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/ageing\/afu145","volume":"44","author":"D O'Mahony","year":"2015","unstructured":"O\u2019Mahony D, O\u2019Sullivan D, Byrne S, O\u2019Connor MN, Ryan C, Gallagher P. STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213\u20138.","journal-title":"Age Ageing"},{"key":"1029_CR3","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/jgs.15767","volume":"67","author":"2019 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel","year":"2019","unstructured":"2019 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel. American Geriatrics Society 2019 Updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67:674\u201394.","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"1029_CR4","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1001\/jamapsychiatry.2014.1763","volume":"72","author":"M Olfson","year":"2015","unstructured":"Olfson M, King M, Schoenbaum M. Benzodiazepine use in the United States. JAMA Psychiat. 2015;72(2):136\u201342.","journal-title":"JAMA Psychiat"},{"issue":"Suppl 1","key":"1029_CR5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/pds.3825","volume":"25","author":"C Huerta","year":"2016","unstructured":"Huerta C, Abbing-Karahagopian V, Requena G, Oliva B, Alvarez Y, Gardarsdottir H, et al. Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project. Pharmacoepidemiol Drug Saf. 2016;25(Suppl 1):56\u201365.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1029_CR6","unstructured":"OCDE. Panorama de la sant\u00e9 2017: Les indicateurs de l\u2019OCDE. \u00c9ditions OCDE; 2017."},{"issue":"5","key":"1029_CR7","doi-asserted-by":"publisher","first-page":"310","DOI":"10.12788\/jhm.2739","volume":"12","author":"EA Pek","year":"2017","unstructured":"Pek EA, Remfry A, Pendrith C, Fan-Lun C, Bhatia RS, Soong C. High prevalence of inappropriate benzodiazepine and sedative hypnotic prescriptions among hospitalized older adults. J Hosp Med. 2017;12(5):310\u20136.","journal-title":"J Hosp Med"},{"issue":"1","key":"1029_CR8","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.eurger.2016.11.012","volume":"8","author":"JB Beuscart","year":"2017","unstructured":"Beuscart JB, Ficheur G, Miqueu M, Luyckx M, Perichon R, Puisieux F, et al. Co-prescriptions of psychotropic drugs to older patients in a general hospital. Eur Geriatr Med. 2017;8(1):84\u20139.","journal-title":"Eur Geriatr Med"},{"issue":"1","key":"1029_CR9","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12877-022-02753-w","volume":"22","author":"F-X Sibille","year":"2022","unstructured":"Sibille F-X, Spinewine A, Zerah L, Maljean L, Schoevaerdts D, de Saint-Hubert M. Current practice in benzodiazepine receptor agonists deprescribing on acute geriatric wards: a cohort study. BMC Geriatr. 2022;22(1):88.","journal-title":"BMC Geriatr"},{"issue":"6","key":"1029_CR10","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/bcp.12732","volume":"80","author":"E Reeve","year":"2015","unstructured":"Reeve E, Gnjidic D, Long J, Hilmer S. A systematic review of the emerging definition of \u201cdeprescribing\u201d with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol. 2015;80(6):1254\u201368.","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"1029_CR11","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s40266-018-0544-4","volume":"35","author":"BJ Ng","year":"2018","unstructured":"Ng BJ, Le Couteur DG, Hilmer SN. Deprescribing benzodiazepines in older patients: impact of interventions targeting physicians, pharmacists, and patients. Drugs Aging. 2018;35(6):493\u2013521.","journal-title":"Drugs Aging"},{"issue":"8","key":"1029_CR12","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s00228-017-2257-8","volume":"73","author":"E Reeve","year":"2017","unstructured":"Reeve E, Ong M, Wu A, Jansen J, Petrovic M, Gnjidic D. A systematic review of interventions to deprescribe benzodiazepines and other hypnotics among older people. Eur J Clin Pharmacol. 2017;73(8):927\u201335.","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"1029_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13012-022-01206-7","volume":"17","author":"P Evrard","year":"2022","unstructured":"Evrard P, P\u00e9tein C, Beuscart J-B, Spinewine A. Barriers and enablers for deprescribing benzodiazepine receptor agonists in older adults: a systematic review of qualitative and quantitative studies using the theoretical domains framework. Implement Sci. 2022;17(1):41.","journal-title":"Implement Sci"},{"issue":"5","key":"1029_CR14","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.japh.2021.04.003","volume":"61","author":"J Choi","year":"2021","unstructured":"Choi J, Vordenberg SE. Older adults\u2019 perceptions of deprescribing chronic benzodiazepines. J Am Pharm Assoc. 2021;61(5):533-538.e3.","journal-title":"J Am Pharm Assoc"},{"issue":"3","key":"1029_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bmjoq-2018-000539","volume":"8","author":"F Carr","year":"2019","unstructured":"Carr F, Tian P, Chow J, Guzak J, Triscott J, Mathura P, et al. Deprescribing benzodiazepines among hospitalised older adults: quality improvement initiative. BMJ Open Qual. 2019;8(3): e000539.","journal-title":"BMJ Open Qual"},{"key":"1029_CR16","doi-asserted-by":"publisher","DOI":"10.1177\/2042098618816562","volume":"10","author":"D Gnjidic","year":"2019","unstructured":"Gnjidic D, Ong HMM, Leung C, Jansen J, Reeve E. The impact of in hospital patient-education intervention on older people\u2019s attitudes and intention to have their benzodiazepines deprescribed: a feasibility study. Ther Adv Drug Saf. 2019;10: 2042098618816562.","journal-title":"Ther Adv Drug Saf"},{"issue":"6","key":"1029_CR17","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1111\/jgs.15300","volume":"66","author":"MG Wilson","year":"2018","unstructured":"Wilson MG, Lee TC, Hass A, Tannenbaum C, McDonald EG. EMPOWERing hospitalized older adults to deprescribe sedative hypnotics: a pilot study. J Am Geriatr Soc. 2018;66(6):1186\u20139.","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"1029_CR18","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1016\/j.sapharm.2021.07.004","volume":"18","author":"HL Neville","year":"2022","unstructured":"Neville HL, Granter C, Adibi P, Belliveau J, Isenor JE, Bowles SK. Interventions to reduce benzodiazepine and sedative-hypnotic drug use in acute care hospitals: a scoping review. Res Soc Admin Pharm RSAP. 2022;18(5):2874\u201386.","journal-title":"Res Soc Admin Pharm RSAP"},{"issue":"6","key":"1029_CR19","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/bcpt.12062","volume":"112","author":"T Graab\u00e6k","year":"2013","unstructured":"Graab\u00e6k T, Kjeldsen LJ. Medication reviews by clinical pharmacists at hospitals lead to improved patient outcomes: a systematic review. Basic Clin Pharmacol Toxicol. 2013;112(6):359\u201373.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"9","key":"1029_CR20","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1111\/jgs.16040","volume":"67","author":"EG McDonald","year":"2019","unstructured":"McDonald EG, Wu PE, Rashidi B, Forster AJ, Huang A, Pilote L, et al. The MedSafer study: a controlled trial of an electronic decision support tool for deprescribing in acute care. J Am Geriatr Soc. 2019;67(9):1843\u201350.","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"1029_CR21","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","volume":"17","author":"N Masnoon","year":"2017","unstructured":"Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):230.","journal-title":"BMC Geriatr"},{"issue":"1","key":"1029_CR22","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12913-020-5056-3","volume":"20","author":"EK Crowley","year":"2020","unstructured":"Crowley EK, Sallevelt B, Huibers CJA, Murphy KD, Spruit M, Shen Z, et al. Intervention protocol: OPtimising thERapy to prevent avoidable hospital Admission in the Multi-morbid elderly (OPERAM): a structured medication review with support of a computerised decision support system. BMC Health Serv Res. 2020;20(1):220.","journal-title":"BMC Health Serv Res"},{"issue":"6","key":"1029_CR23","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-026769","volume":"9","author":"L Adam","year":"2019","unstructured":"Adam L, Moutzouri E, Baumgartner C, Loewe AL, Feller M, M\u2019Rabet-Bensalah K, et al. Rationale and design of OPtimising thERapy to prevent Avoidable hospital admissions in Multimorbid older people (OPERAM): a cluster randomised controlled trial. BMJ Open. 2019;9(6): e026769.","journal-title":"BMJ Open"},{"issue":"374","key":"1029_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1585","volume":"13","author":"MR Blum","year":"2021","unstructured":"Blum MR, Sallevelt B, Spinewine A, O\u2019Mahony D, Moutzouri E, Feller M, et al. Optimizing Therapy to Prevent Avoidable Hospital Admissions in Multimorbid Older Adults (OPERAM): cluster randomised controlled trial. BMJ. 2021;13(374): n1585.","journal-title":"BMJ"},{"issue":"5","key":"1029_CR25","first-page":"339","volume":"64","author":"K Pottie","year":"2018","unstructured":"Pottie K, Thompson W, Davies S, Grenier J, Sadowski CA, Welch V, et al. Deprescribing benzodiazepine receptor agonists: evidence-based clinical practice guideline. Can Fam Physician. 2018;64(5):339\u201351.","journal-title":"Can Fam Physician"},{"issue":"11","key":"1029_CR26","doi-asserted-by":"publisher","first-page":"915","DOI":"10.2165\/11584480-000000000-00000","volume":"27","author":"J Joester","year":"2010","unstructured":"Joester J, Vogler CM, Chang K, Hilmer SN. Hypnosedative use and predictors of successful withdrawal in new patients attending a falls clinic: a retrospective, cohort study. Drugs Aging. 2010;27(11):915\u201324.","journal-title":"Drugs Aging"},{"issue":"2","key":"1029_CR27","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s11096-019-00797-4","volume":"41","author":"T Aoki","year":"2019","unstructured":"Aoki T, Yamamoto Y, Ikenoue T, Fukuhara S. Factors associated with patient preferences towards deprescribing: a survey of adult patients on prescribed medications. Int J Clin Pharm. 2019;41(2):531\u20137.","journal-title":"Int J Clin Pharm"},{"issue":"3","key":"1029_CR28","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1590\/S0102-311X2009000300015","volume":"25","author":"JM Alvarenga","year":"2009","unstructured":"Alvarenga JM, Loyola Filho AI, Firmo JO, Lima-Costa MF, Uchoa E. A population based study on health conditions associated with the use of benzodiazepines among older adults (The Bambu\u00ed Health and Aging Study). Cad Saude Publica. 2009;25(3):605\u201312.","journal-title":"Cad Saude Publica"},{"key":"1029_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2019.106195","volume":"102","author":"A Allary","year":"2020","unstructured":"Allary A, Proulx-Tremblay V, B\u00e9langer C, Hudon C, Marchand A, O\u2019Connor K, et al. Psychological predictors of benzodiazepine discontinuation among older adults: results from the PASSE 60. Addict Behav. 2020;102: 106195.","journal-title":"Addict Behav"},{"issue":"2","key":"1029_CR30","first-page":"163","volume":"9","author":"AL Couderc","year":"2011","unstructured":"Couderc AL, Bailly-Agaledes C, Camalet J, Capriz-Ribi\u00e8re F, Gary A, Robert P, et al. Adaptations of psychotropic drugs in patients aged 75 years and older in a departement of geriatric internal medecine: report of 100 cases. Geriatr Psychol Neuropsychiatr Vieil. 2011;9(2):163\u201370.","journal-title":"Geriatr Psychol Neuropsychiatr Vieil"},{"key":"1029_CR31","unstructured":"(WHO) WHO. ICD-10 Version:2016; 2021."},{"issue":"2","key":"1029_CR32","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1097\/MLR.0000000000000471","volume":"54","author":"A Bannay","year":"2016","unstructured":"Bannay A, Chaignot C, Bloti\u00e8re PO, Basson M, Weill A, Ricordeau P, et al. The best use of the Charlson comorbidity index with electronic health care database to predict mortality. Med Care. 2016;54(2):188\u201394.","journal-title":"Med Care"},{"issue":"6","key":"1029_CR33","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1056\/NEJMcp042262","volume":"352","author":"R Saitz","year":"2005","unstructured":"Saitz R. Clinical practice. Unhealthy alcohol use. N Engl J Med. 2005;352(6):596\u2013607.","journal-title":"N Engl J Med"},{"key":"1029_CR34","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1001\/jama.1963.03060120024016","volume":"185","author":"S Katz","year":"1963","unstructured":"Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA. 1963;185:914\u20139.","journal-title":"JAMA"},{"issue":"11","key":"1029_CR35","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1097\/00005650-199711000-00002","volume":"35","author":"P Dolan","year":"1997","unstructured":"Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997;35(11):1095\u2013108.","journal-title":"Med Care"},{"issue":"3","key":"1029_CR36","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1001\/jamainternmed.2021.7429","volume":"182","author":"EG McDonald","year":"2022","unstructured":"McDonald EG, Wu PE, Rashidi B, Wilson MG, Bortolussi-Courval \u00c9, Atique A, et al. The MedSafer study-electronic decision support for deprescribing in hospitalized older adults: a cluster randomized clinical trial. JAMA Intern Med. 2022;182(3):265\u201373.","journal-title":"JAMA Intern Med"},{"issue":"4","key":"1029_CR37","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.phclin.2018.04.003","volume":"53","author":"E Chambost","year":"2018","unstructured":"Chambost E, Chappuy M. Impact de la nouvelle r\u00e9glementation du zolpidem\u2014enqu\u00eate dans la circonscription d\u00e9partementale du Rh\u00f4ne. Le Pharmacien Hospitalier et Clinicien. 2018;53(4):288\u2013300.","journal-title":"Le Pharmacien Hospitalier et Clinicien"},{"issue":"4","key":"1029_CR38","doi-asserted-by":"publisher","first-page":"371.e11","DOI":"10.1016\/j.jamda.2017.12.098","volume":"19","author":"LJ Seppala","year":"2018","unstructured":"Seppala LJ, Wermelink A, de Vries M, Ploegmakers KJ, van de Glind EMM, Daams JG, et al. Fall-risk-increasing drugs: a systematic review and meta-analysis: II. Psychotropics. J Am Med Dir Assoc. 2018;19(4):371.e11-371.e17.","journal-title":"J Am Med Dir Assoc"},{"issue":"8","key":"1029_CR39","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1056\/NEJMcp1903252","volume":"382","author":"DA Ganz","year":"2020","unstructured":"Ganz DA, Latham NK. Prevention of falls in community-dwelling older adults. N Engl J Med. 2020;382(8):734\u201343.","journal-title":"N Engl J Med"},{"issue":"1","key":"1029_CR40","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S2215-0366(16)30348-0","volume":"4","author":"A Riecher-R\u00f6ssler","year":"2017","unstructured":"Riecher-R\u00f6ssler A. Sex and gender differences in mental disorders. Lancet Psychiatry. 2017;4(1):8\u20139.","journal-title":"Lancet Psychiatry"},{"issue":"7","key":"1029_CR41","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1089\/jwh.2014.4816","volume":"23","author":"MP Mallampalli","year":"2014","unstructured":"Mallampalli MP, Carter CL. Exploring sex and gender differences in sleep health: a Society for Women\u2019s Health Research Report. J Womens Health (Larchmt). 2014;23(7):553\u201362.","journal-title":"J Womens Health (Larchmt)"},{"key":"1029_CR42","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.maturitas.2019.09.004","volume":"129","author":"KM Kiely","year":"2019","unstructured":"Kiely KM, Brady B, Byles J. Gender, mental health and ageing. Maturitas. 2019;129:76\u201384.","journal-title":"Maturitas"},{"issue":"3","key":"1029_CR43","volume":"3","author":"L Baandrup","year":"2018","unstructured":"Baandrup L, Ebdrup BH, Rasmussen J, Lindschou J, Gluud C, Glenth\u00f8j BY. Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users. Cochrane Database Syst Rev. 2018;3(3): CD011481.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"1029_CR44","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s11096-018-0673-1","volume":"40","author":"S Scott","year":"2018","unstructured":"Scott S, Clark A, Farrow C, May H, Patel M, Twigg MJ, et al. Deprescribing admission medication at a UK teaching hospital; a report on quantity and nature of activity. Int J Clin Pharm. 2018;40(5):991\u20136.","journal-title":"Int J Clin Pharm"},{"key":"1029_CR45","first-page":"1695","volume":"10","author":"T Halvorsen","year":"2015","unstructured":"Halvorsen T, Martinussen PE. Benzodiazepine use in COPD: empirical evidence from Norway. Int J Chron Obstruct Pulmon Dis. 2015;10:1695\u2013702.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"1","key":"1029_CR46","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s40266-021-00904-z","volume":"39","author":"B Sallevelt","year":"2022","unstructured":"Sallevelt B, Huibers CJA, Heij J, Egberts TCG, van Puijenbroek EP, Shen Z, et al. Frequency and acceptance of clinical decision support system-generated STOPP\/START signals for hospitalised older patients with polypharmacy and multimorbidity. Drugs Aging. 2022;39(1):59\u201373.","journal-title":"Drugs Aging"},{"key":"1029_CR47","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s41999-022-00633-5","volume":"13","author":"CJA Huibers","year":"2022","unstructured":"Huibers CJA, Sallevelt BTGM, Heij JMJ, O\u2019Mahony D, Rodondi N, Dalleur O, et al. Hospital physicians\u2019 and older patients\u2019 agreement with individualised STOPP\/START-based medication optimisation recommendations in a clinical trial setting. Eur Geriatr Med. 2022;13:541\u201352.","journal-title":"Eur Geriatr Med"},{"issue":"1","key":"1029_CR48","doi-asserted-by":"publisher","first-page":"54","DOI":"10.29090\/psa.2019.01.017.0023","volume":"46","author":"T Xuan Vu","year":"2019","unstructured":"Xuan Vu T, Bui Thi Huong Q. The effect of the pharmacist\u2019s intervention on potentially inappropriate medication use in older adults using the 2015 Beers criteria. Pharm Sci Asia. 2019;46(1):54\u201361.","journal-title":"Pharm Sci Asia"},{"issue":"2","key":"1029_CR49","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/ageing\/afaa169","volume":"50","author":"S Scott","year":"2020","unstructured":"Scott S, May H, Patel M, Wright DJ, Bhattacharya D. A practitioner behaviour change intervention for deprescribing in the hospital setting. Age Ageing. 2020;50(2):581\u20136.","journal-title":"Age Ageing"},{"issue":"9","key":"1029_CR50","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1111\/imj.15208","volume":"51","author":"AD Nguyen","year":"2021","unstructured":"Nguyen AD, Baysari MT, Duong M, Zheng WY, Ng B, Lo S, et al. Communicating deprescribing decisions made in hospital with general practitioners in the community. Intern Med J. 2021;51(9):1473\u20138.","journal-title":"Intern Med J"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-023-01029-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-023-01029-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-023-01029-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,20]],"date-time":"2024-10-20T23:36:41Z","timestamp":1729467401000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-023-01029-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,23]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["1029"],"URL":"https:\/\/doi.org\/10.1007\/s40266-023-01029-1","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,23]]},"assertion":[{"value":"4 April 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work is part of the project \u201cOPERAM: OPtimising thERapy to prevent Avoidable hospital admissions in the Multimorbid elderly\u201d supported by the European Union's Horizon 2020 research and innovation program under the grant agreement No. 634238, and by the Swiss State Secretariat for Education, Research and Innovation (SERI) under contract number 15.0137. The OPERAM project was also partially funded by the Swiss National Scientific Foundation (SNSF 320030_188549 and 325130_204361). Fran\u00e7ois-Xavier Sibille is a Clinical Master Specialist Applicant for a Ph.D. of the Fonds de la Recherche Scientifique\u2014FNRS. The opinions expressed herein are those of the authors and do not necessarily reflect the official views of the funders. The funders had no role in the study design; data collection, analysis, and interpretation; or writing of the report. Open access funding was provided by UCLouvain and CHU UCL Namur.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Fran\u00e7ois-Xavier Sibille is a Clinical Master Specialist Applicant for a Ph.D. of the Fonds de la Recherche Scientifique\u2014FNRS. The funder had no role in study design, data collection, data analysis, data interpretation, or writing of the report. All other authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The datasets analyzed during the current study will be made available on reasonable request. Data will be made available for scientific purposes for researchers whose proposed use of the data has been approved by the OPERAM publication committee.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability"}},{"value":"The OPERAM trial was approved by the independent research ethics committees at each participating site (lead ethics committee: Cantonal Ethics Committee Bern, Switzerland, ID 2016-01200; Medical Research Ethics Committee Utrecht, the Netherlands, ID 15-522\/D; Comit\u00e9 d\u2019Ethique Hospitalo-Facultaire Saint-Luc-UCL: 2016\/20JUL\/347\u2013Belgian registration No: B403201629175; Cork University Teaching Hospitals Clinical Ethics Committee, Cork, Republic of Ireland; ID ECM 4 [o] 07\/02\/17), and Swissmedic as the responsible regulatory authority. The authors certify that the study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Written informed consent was obtained from the participants or their legal representatives before enrollment in the OPERAM trial.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The codes used during the current study will be made available on reasonable request.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Authorship eligibility is based on the International Committee of Medical Journal Editors (ICMJE) authorship criteria. The authors certify that they have participated in the following aspects: conception and design (all authors); acquisition and interpretation of data (FXS, MdSH, SH, AS); drafting the article (FXS, MdSH, AS) and revising it critically for important intellectual content (all authors). All authors have approved the final article, and agree to be accountable for the work.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}